The pharmaceutical company, which invested $45m in Quanticel in 2011, will pay $100m up front and up to $385m in milestone payments.

The gene editing technology company has raised $64m to close its first two rounds, co-led by Celgene and GlaxoSmithKline-backed SR One, at $89m.

The milestone-based licensing deal includes a $29m investment up front and could be worth more than $400m to the small molecule technology developer.

University hospitals in the US trial home-use wearable technology to track pregnancies.

Corporates Fosun and Tencent co-led the round for the mobile medical devices maker, taking its overall funding to almost $50m.

Canon has invested an undisclosed amount of capital in the DNA testing service provider as part of a strategic collaboration.

University Technical College, Cambridge, encourages its students to consider working in the biotechnology sector in a collaboration with MedImmune.